Source: GlobalNewswire

Press Release: National Race To End Women's Cancer : The Foundation for Women's Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women's Cancer

CHICAGO and WALTHAM, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- The Foundation for Women's Cancer (FWC), the official foundation of the Society of Gynecologic Oncology, and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the continuation of their partnership supporting the annual National Race to End Women's Cancer. TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women's Cancer, the FWC's pinnacle awareness and fundraising event, bringing families and friends from across the country together to support women with gynecologic cancers. The event features a 5K run and 1 mile walk on Sunday, Nov. 5, along Pennsylvania Avenue, NW in Washington, D.C.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100